Edgewise Therapeutics, Inc. (EWTX) Operating income 2020–2025
Edgewise Therapeutics, Inc. (EWTX) annual operating income history from SEC filings — each fiscal year as reported.
-$191.4MFY2025 · since FY2020: -$17.2M → -$191.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$191.4M | -20.5% |
| FY2024 | -$158.8M | -38.9% |
| FY2023 | -$114.4M | -59.6% |
| FY2022 | -$71.7M | -65.8% |
| FY2021 | -$43.2M | -151.4% |
| FY2020 | -$17.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice